Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Watson Has Double-Digit Upside, But Peers Are 'Strong Buys'
Watson Has Double-Digit Upside, But Peers Are 'Strong Buys'
Watson Has Double-Digit Upside, But Peers Are 'Strong Buys'
Submitted by
admin
on May 11, 2012 - 12:36pm
Source:
Seeking Alpha
News Tags:
Watson Pharmaceuticals
JNJ
Novartis
Pfizer
Headline:
Watson Has Double-Digit Upside, But Peers Are 'Strong Buys'
Do Not Allow Advertisers to Use My Personal information
